Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kit S Lam

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
Bioactive Materials|June 6, 2022
A bioactive material with dual integrin-targeting ligands regulates specific endogenous cell adhesion and promotes vascularized bone regeneration in adult and fetal bone defectsDake Hao, Ruiwu Liu, Tomas Gonzalez Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder CancerZheng Zhu, Ai-Hong Ma, Hongyong Zhang, et al.
Nature Communications|August 27, 2014
A smart and versatile theranostic nanomedicine platform based on nanoporphyrinYuanpei Li, Tzu-Yin Lin, Yan Luo, et al.
Plos One|August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitorsWenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2005
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acidKatsushi Amano, Patrick S C Leung, Roman Rieger, et al.
Hepatology (Baltimore, Md.)|June 20, 2008
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular diseaseKanji Wakabayashi, Zhe-Xiong Lian, Patrick S C Leung, et al.
Journal of Dermatological Science|April 25, 2017
ITK inhibition for the targeted treatment of CTCLItzel Bustos-Villalobos, Jennifer Williams Bergstrom, Nathan E Haigh, et al.
Circulation Research|December 9, 2015
Multimodal SHG-2PF Imaging of Microdomain Ca2+-Contraction Coupling in Live Cardiac MyocytesSamir Awasthi, Leighton T Izu, Ziliang Mao, et al.
Cancer Journal (Sudbury, Mass.)|November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in CaliforniaCynthia L Martel, Yueju Li, Laurel Beckett, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2015
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional CharacterizationWei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
Bioactive Materials|June 6, 2022
A bioactive material with dual integrin-targeting ligands regulates specific endogenous cell adhesion and promotes vascularized bone regeneration in adult and fetal bone defectsDake Hao, Ruiwu Liu, Tomas Gonzalez Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder CancerZheng Zhu, Ai-Hong Ma, Hongyong Zhang, et al.
Nature Communications|August 27, 2014
A smart and versatile theranostic nanomedicine platform based on nanoporphyrinYuanpei Li, Tzu-Yin Lin, Yan Luo, et al.
Plos One|August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitorsWenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2005
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acidKatsushi Amano, Patrick S C Leung, Roman Rieger, et al.
Hepatology (Baltimore, Md.)|June 20, 2008
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular diseaseKanji Wakabayashi, Zhe-Xiong Lian, Patrick S C Leung, et al.
Journal of Dermatological Science|April 25, 2017
ITK inhibition for the targeted treatment of CTCLItzel Bustos-Villalobos, Jennifer Williams Bergstrom, Nathan E Haigh, et al.
Circulation Research|December 9, 2015
Multimodal SHG-2PF Imaging of Microdomain Ca2+-Contraction Coupling in Live Cardiac MyocytesSamir Awasthi, Leighton T Izu, Ziliang Mao, et al.
Cancer Journal (Sudbury, Mass.)|November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in CaliforniaCynthia L Martel, Yueju Li, Laurel Beckett, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2015
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional CharacterizationWei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, et al.
Pageof 27